Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
An open-label, long-term extension study to evaluate safety and efficacy in participants treated with CRN04894
Sarafoglou, K. M. (PI)
CRINETICS PHARMACEUTICALS, INC
11/1/24 → 12/1/25
Project: Research project
-
A Phase 2, Randomized, Human Growth Hormone-Controlled,Multicenter, Basket Study of Vosoritide in Children with Turner Syndrome, ShortStature Homeobox-Containing Gene Deficiency, and Noonan Syndrome with anInadequate Response to Human Growth Hormone
Sarafoglou, K. M. (PI)
8/1/24 → 9/9/35
Project: Research project
-
Frontiers in Congenital Disorders of Glycosylation
Sarafoglou, K. M. (PI) & Miller, B. S. (CoI)
MOUNT SINAI SCHOOL OF MEDICINE, NATIONAL INSTITUTES OF HEALTH (NIH)
4/24/24 → 7/31/25
Project: Research project
-
A methodology study to evaluate aspects of compliance, usability, analytical validity, construct validity,operational reliability, and content validity of a novel digital outcome measure in adults withhypophosphatasia using an Apple iPhone?? and Centre
Sarafoglou, K. M. (PI)
3/21/24 → 3/31/34
Project: Research project
-
A Phase 3, Randomized, Open-label, Parallel-arm, Active-controlled, Multicenter Study to Evaluate Safetyand Efficacy of ALXN1850 Versus Asfotase Alfa Administered Subcutaneously in Pediatric (2 to < 12 yearsof age) Participants with Hypophosphatasia (H
Sarafoglou, K. M. (PI)
11/21/23 → 11/30/33
Project: Research project
-
Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue
Halper, A., Sanchez, B., Hodges, J. S., Dengel, D. R., Petryk, A. & Sarafoglou, K., Jul 2019, In: Clinical endocrinology. 91, 1, p. 124-130 7 p.Research output: Contribution to journal › Article › peer-review
18 Scopus citations -
Interrelationships among cortisol, 17-hydroxyprogesterone, and androstenendione exposures in the management of children with congenital adrenal hyperplasia
Sarafoglou, K., Zimmerman, C. L., Gonzalez-Bolanos, M. T., Willis, B. A. & Brundage, R., Jan 2015, In: Journal of Investigative Medicine. 63, 1, p. 35-41 7 p.Research output: Contribution to journal › Article › peer-review
23 Scopus citations -
Impact of hydrocortisone on adult height in congenital adrenal hyperplasia - The Minnesota cohort
Sarafoglou, K., Addo, O. Y., Turcotte, L., Otten, N., Wickremasinghe, A., Pittock, S., Kyllo, J., Lteif, A. N., Himes, J. H. & Miller, B. S., 2014, In: Journal of Pediatrics. 164, 5, p. 1141-1146.e1Research output: Contribution to journal › Article › peer-review
39 Scopus citations -
Comparison of cortisol exposures and pharmacodynamic adrenal steroid responses to hydrocortisone suspension VS. Commercial tablets
Sarafoglou, K., Gonzalez-Bolanos, M. T., Zimmerman, C. L., Boonstra, T., Yaw Addo, O. & Brundage, R., Apr 2015, In: Journal of Clinical Pharmacology. 55, 4, p. 452-457 6 p.Research output: Contribution to journal › Article › peer-review
16 Scopus citations -
Comparison of one-tier and two-tier newborn screening metrics for congenital adrenal hyperplasia
Sarafoglou, K., Banks, K., Gaviglio, A., Hietala, A., McCann, M. & Thomas, W., Nov 2012, In: Pediatrics. 130, 5, p. e1261-e1268Research output: Contribution to journal › Article › peer-review
60 Scopus citations